LAMEA Oral Antiviral Market Size, Share & Industry Trends Analysis Report By Indication (Human Immunodeficiency Virus (HIV), Hepatitis, Influenza), By Drug Class, By Distribution Channel, By Country and Growth Forecast, 2023 - 2029

The Latin America, Middle East and Africa Oral Antiviral Market would witness market growth of 5.4% CAGR during the forecast period (2023-2029).

The market is predicted to increase quickly due to the therapeutic landscape's shift toward biologics and increasing understanding of molecular mechanisms. Furthermore, the newly produced product is being given special drug designation by the regulatory authorities, which benefits the vendors and helps to increase sales of oral antiviral medications, which will help the market grow in the upcoming years.

Time is needed, and market income and profit are constrained as a safe, effective, and tailored antiviral is developed from the ground up. In addition, potential viral pandemics highlight the requirement for broad-spectrum antiviral drugs, such as direct-acting antivirals, that can be quickly and broadly applied to stop viral spread until suitable vaccinations are created. The market is also anticipated to be constrained by a growing understanding of vaccination accessibility and infection prevention techniques.

The Saudi Arabian government's Vision 2030 plans to spend $65 billion to build the nation's healthcare system. Additionally, by 2030, it plans to increase the private sector's participation from 405 to 65%. Furthermore, they want to privatize 2,300 major health facilities, including 290 hospitals. The Ministry of Healthcare also intends to establish a health cluster throughout Saudi Arabia to advance integrated and preventative care and improve access to healthcare services. Growing healthcare spending and infrastructure will encourage regional market expansion by encouraging market participants to invest in and diversify their regional activities.

The Brazil market dominated the LAMEA Oral Antiviral Market by Country in 2022 thereby, achieving a market value of $700.2 million by 2029. The Argentina market is experiencing a CAGR of 6% during (2023 - 2029). Additionally, The UAE market would exhibit a CAGR of 5.1% during (2023 - 2029).

Based on Indication, the market is segmented into Human Immunodeficiency Virus (HIV), Hepatitis, Influenza and Others. Based on Drug Class, the market is segmented into Reverse Transcriptase Inhibitors, Protease Inhibitors and Others. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Worldwide Oral Antiviral Market is Projected to reach USD 41.2 Billion by 2029, at a CAGR of 2.3%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bristol Myers Squibb Company, Gilead Sciences, Inc., Viatris, Inc. (Mylan N.V.), AbbVie, Inc., GlaxoSmithKline PLC (GSK), Teva Pharmaceutical Industries Ltd., and Amneal Pharmaceuticals, Inc.

Scope of the Study

Market Segments Covered in the Report:

By Indication

• Human Immunodeficiency Virus (HIV)
• Hepatitis
• Influenza
• Others

By Drug Class

• Reverse Transcriptase Inhibitors
• Protease Inhibitors
• Others

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Providers

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Johnson & Johnson
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Gilead Sciences, Inc.
• Viatris, Inc. (Mylan N.V.)
• AbbVie, Inc.
• GlaxoSmithKline PLC (GSK)
• Teva Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals, Inc.

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Oral Antiviral Market, by Indication
1.4.2 LAMEA Oral Antiviral Market, by Drug Class
1.4.3 LAMEA Oral Antiviral Market, by Distribution Channel
1.4.4 LAMEA Oral Antiviral Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. LAMEA Oral Antiviral Market by Indication
3.1 LAMEA Human Immunodeficiency Virus (HIV) Market by Country
3.2 LAMEA Hepatitis Market by Country
3.3 LAMEA Influenza Market by Country
3.4 LAMEA Others Market by Country

Chapter 4. LAMEA Oral Antiviral Market by Drug Class
4.1 LAMEA Reverse Transcriptase Inhibitors Market by Country
4.2 LAMEA Protease Inhibitors Market by Country
4.3 LAMEA Others Market by Country

Chapter 5. LAMEA Oral Antiviral Market by Distribution Channel
5.1 LAMEA Drug Store & Retail Pharmacies Market by Country
5.2 LAMEA Hospital Pharmacies Market by Country
5.3 LAMEA Online Providers Market by Country

Chapter 6. LAMEA Oral Antiviral Market by Country
6.1 Brazil Oral Antiviral Market
6.1.1 Brazil Oral Antiviral Market by Indication
6.1.2 Brazil Oral Antiviral Market by Drug Class
6.1.3 Brazil Oral Antiviral Market by Distribution Channel
6.2 Argentina Oral Antiviral Market
6.2.1 Argentina Oral Antiviral Market by Indication
6.2.2 Argentina Oral Antiviral Market by Drug Class
6.2.3 Argentina Oral Antiviral Market by Distribution Channel
6.3 UAE Oral Antiviral Market
6.3.1 UAE Oral Antiviral Market by Indication
6.3.2 UAE Oral Antiviral Market by Drug Class
6.3.3 UAE Oral Antiviral Market by Distribution Channel
6.4 Saudi Arabia Oral Antiviral Market
6.4.1 Saudi Arabia Oral Antiviral Market by Indication
6.4.2 Saudi Arabia Oral Antiviral Market by Drug Class
6.4.3 Saudi Arabia Oral Antiviral Market by Distribution Channel
6.5 South Africa Oral Antiviral Market
6.5.1 South Africa Oral Antiviral Market by Indication
6.5.2 South Africa Oral Antiviral Market by Drug Class
6.5.3 South Africa Oral Antiviral Market by Distribution Channel
6.6 Nigeria Oral Antiviral Market
6.6.1 Nigeria Oral Antiviral Market by Indication
6.6.2 Nigeria Oral Antiviral Market by Drug Class
6.6.3 Nigeria Oral Antiviral Market by Distribution Channel
6.7 Rest of LAMEA Oral Antiviral Market
6.7.1 Rest of LAMEA Oral Antiviral Market by Indication
6.7.2 Rest of LAMEA Oral Antiviral Market by Drug Class
6.7.3 Rest of LAMEA Oral Antiviral Market by Distribution Channel

Chapter 7. Company Profiles
7.1 Johnson & Johnson
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental &Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 SWOT Analysis
7.2 F. Hoffmann-La Roche Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Merck & Co., Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Bristol Myers Squibb Company
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Gilead Sciences, Inc.
7.5.1 Company overview
7.5.2 Financial Analysis
7.5.3 Research & Development Expenses
7.6 Viatris, Inc. (Mylan N.V.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expense
7.7 AbbVie, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expense
7.8 GlaxoSmithKline PLC (GSK)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research & Development Expense
7.9 Teva Pharmaceutical Industries Ltd.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Amneal Pharmaceuticals, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental Analysis
7.10.4 Research & Development Expenses

TABLE 1 LAMEA Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 2 LAMEA Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 3 LAMEA Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 4 LAMEA Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 5 LAMEA Human Immunodeficiency Virus (HIV) Market by Country, 2019 - 2022, USD Million
TABLE 6 LAMEA Human Immunodeficiency Virus (HIV) Market by Country, 2023 - 2029, USD Million
TABLE 7 LAMEA Hepatitis Market by Country, 2019 - 2022, USD Million
TABLE 8 LAMEA Hepatitis Market by Country, 2023 - 2029, USD Million
TABLE 9 LAMEA Influenza Market by Country, 2019 - 2022, USD Million
TABLE 10 LAMEA Influenza Market by Country, 2023 - 2029, USD Million
TABLE 11 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 12 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 13 LAMEA Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 14 LAMEA Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 15 LAMEA Reverse Transcriptase Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 16 LAMEA Reverse Transcriptase Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 17 LAMEA Protease Inhibitors Market by Country, 2019 - 2022, USD Million
TABLE 18 LAMEA Protease Inhibitors Market by Country, 2023 - 2029, USD Million
TABLE 19 LAMEA Others Market by Country, 2019 - 2022, USD Million
TABLE 20 LAMEA Others Market by Country, 2023 - 2029, USD Million
TABLE 21 LAMEA Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 22 LAMEA Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 23 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 24 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 25 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
TABLE 26 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
TABLE 27 LAMEA Online Providers Market by Country, 2019 - 2022, USD Million
TABLE 28 LAMEA Online Providers Market by Country, 2023 - 2029, USD Million
TABLE 29 LAMEA Oral Antiviral Market by Country, 2019 - 2022, USD Million
TABLE 30 LAMEA Oral Antiviral Market by Country, 2023 - 2029, USD Million
TABLE 31 Brazil Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 32 Brazil Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 33 Brazil Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 34 Brazil Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 35 Brazil Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 36 Brazil Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 37 Brazil Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 38 Brazil Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 39 Argentina Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 40 Argentina Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 41 Argentina Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 42 Argentina Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 43 Argentina Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 44 Argentina Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 45 Argentina Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 46 Argentina Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 47 UAE Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 48 UAE Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 49 UAE Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 50 UAE Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 51 UAE Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 52 UAE Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 53 UAE Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 54 UAE Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 55 Saudi Arabia Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 56 Saudi Arabia Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 57 Saudi Arabia Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 58 Saudi Arabia Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 59 Saudi Arabia Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 60 Saudi Arabia Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 61 Saudi Arabia Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 62 Saudi Arabia Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 63 South Africa Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 64 South Africa Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 65 South Africa Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 66 South Africa Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 67 South Africa Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 68 South Africa Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 69 South Africa Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 70 South Africa Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 71 Nigeria Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 72 Nigeria Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 73 Nigeria Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 74 Nigeria Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 75 Nigeria Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 76 Nigeria Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 77 Nigeria Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 78 Nigeria Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 79 Rest of LAMEA Oral Antiviral Market, 2019 - 2022, USD Million
TABLE 80 Rest of LAMEA Oral Antiviral Market, 2023 - 2029, USD Million
TABLE 81 Rest of LAMEA Oral Antiviral Market by Indication, 2019 - 2022, USD Million
TABLE 82 Rest of LAMEA Oral Antiviral Market by Indication, 2023 - 2029, USD Million
TABLE 83 Rest of LAMEA Oral Antiviral Market by Drug Class, 2019 - 2022, USD Million
TABLE 84 Rest of LAMEA Oral Antiviral Market by Drug Class, 2023 - 2029, USD Million
TABLE 85 Rest of LAMEA Oral Antiviral Market by Distribution Channel, 2019 - 2022, USD Million
TABLE 86 Rest of LAMEA Oral Antiviral Market by Distribution Channel, 2023 - 2029, USD Million
TABLE 87 Key information –Johnson & Johnson
TABLE 88 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 89 KEY INFORMATION - Merck & Co., Inc.
TABLE 90 Key Information – Bristol Myers Squibb Company
TABLE 91 Key Information – Gilead Sciences, Inc.
TABLE 92 key information – Viatris, Inc.
TABLE 93 Key information – AbbVie, Inc.
TABLE 94 Key Information – GlaxoSmithKline PLC
TABLE 95 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 96 Key Information – Amneal Pharmaceuticals, INc.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Oral Antiviral Market Share by Indication, 2022
FIG 3 LAMEA Oral Antiviral Market Share by Indication, 2029
FIG 4 LAMEA Oral Antiviral Market by Indication, 2019 - 2029, USD Million
FIG 5 LAMEA Oral Antiviral Market Share by Drug Class, 2022
FIG 6 LAMEA Oral Antiviral Market Share by Drug Class, 2029
FIG 7 LAMEA Oral Antiviral Market by Drug Class, 2019 - 2029, USD Million
FIG 8 LAMEA Oral Antiviral Market Share by Distribution Channel, 2022
FIG 9 LAMEA Oral Antiviral Market Share by Distribution Channel, 2029
FIG 10 LAMEA Oral Antiviral Market by Distribution Channel, 2019 - 2029, USD Million
FIG 11 LAMEA Oral Antiviral Market Share by Country, 2022
FIG 12 LAMEA Oral Antiviral Market Share by Country, 2029
FIG 13 LAMEA Oral Antiviral Market by Country, 2019 - 2029, USD Million
FIG 14 SWOT analysis: Johnson & Johnson